Marseglia G L, Marchi A, Zecca M, Pedrazzoli P, Locatelli F
Department of Pediatrics, University of Pavia, Italy.
J Pediatr. 1994 Sep;125(3):403-5. doi: 10.1016/s0022-3476(05)83285-8.
A 4-year-old white boy with immune-mediated red cell aplasia and severe anemia was given high intravenous doses of gamma-globulin. The therapy was well tolerated and followed by complete resolution of the inhibition of erythropoiesis with no recurrence of disease. Eight months after discontinuation of treatment, the patient has a normal complete blood cell count.
一名患有免疫介导性红细胞再生障碍和严重贫血的4岁白人男孩接受了大剂量静脉注射丙种球蛋白治疗。该治疗耐受性良好，随后红细胞生成抑制完全缓解，且疾病未复发。在停止治疗8个月后，患者的全血细胞计数恢复正常。
